Skip to content

Pharmaceutical Crystallization Summit

Breaking Drug Development Bottlenecks via Enabling Technologies

October 14-15, 2021

  • Home
  • Program
    • Program for Live Attendance
    • Program for Virtual Attendance
  • Abstracts
    • Session 1: Smarter Solid Form & Pre-formulation Studies
    • Session 2: Particle Engineering & DS-DP Co-Processing
    • Session 3: Physical Property Based Crystallization Process Development
  • Keynote Speakers & Moderators
  • Venue
    • Chauncey Hotel & Conference Center
    • COVID-19 Safety Protocols
    • Destination Guide
  • Partners
    • Center for Pharma Crystallization
    • J-STAR Research, Inc.
    • Porton Pharma Solutions Ltd.
    • XtalPi
    • BlazeMetrics
    • Technobis Crystallization Systems
  • COVID-19 Prevention
    • Chauncey’s Health & Safety Plan
    • PCS COVID-19 Prevention

Session 2: Particle Engineering & DS-DP Co-Processing

Moderator: Dr. San Kiang, J-Star/Porton

Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing

Dr. Christopher Burcham, Eli Lilly and Company

Read More

Crystal Habit Modifications and Spherical Crystallization Design in Solution

Prof. Junbo Gong, Tianjin University

Read More

Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients

Prof. Calvin Changquan Sun, University of Minnesota

Read More

Bridging the Gap between Drug Substance and Drug Product Processing via Co-Processing

Dr. Jian Wang, CfPC/J-Star/Porton

Read More

Abstracts

  • Abstracts (15)
    • Session 1: Smarter Solid Form & Pre-formulation Studies (4)
    • Session 2: Particle Engineering & DS-DP Co-Processing (4)
    • Session 3: Physical Property Based Crystallization Process Development (4)
    • Session 4: Topical Panel Discussions (3)

© 2021 Pharmaceutical Crystallization Summit. All Rights Reserved.

Scroll To Top